FDA’s plan to propose ban on formaldehyde in hair-straightening products remains in limbo under Trump administration
A plan for the US Food and Drug Administration to propose banning formaldehyde and certain formaldehyde-releasing chemicals ...
FDA fast tracks NKGen's Alzheimer's therapy troculeucel
SANTA ANA, Calif. - NKGen Biotech, Inc. (NASDAQ: NKGN), a clinical-stage biotechnology company with a current market ...
Botulism fears prompt FDA to recall some canned tuna sold at popular retailers
A pull-tab defect that might cause leakage and lead to botulism contamination is affecting some canned tuna products sold in ...
US FDA approves SpringWorks' genetic disorder drug
The U.S. Food and Drug Administration said on Tuesday it has approved SpringWorks Therapeutics' drug to treat a type of rare ...
FDA approves new genetic disorder drug
The Food and Drug Administration (FDA) approved a new drug to treat a disorder causing the growth of non-cancerous tumors on ...
FiercePharma2h
Amid takeover talk, SpringWorks scores FDA nod for rare genetic disease treatment Gomekli
Tuesday, the agency signed off on SpringWorks’ Gomekli (mirdametinib) as a treatment for the rare genetic disorder ...
Canned Tuna Sold at Trader Joe's, Costco and Walmart Recalled, FDA Warns of 'Potentially Fatal' Contamination
Select tuna cans sold under Trader Joe's in-house brand, Genova and Van Camp's labels are included in the recall ...
Rolling Out22h
FDA recalls millions of Dunkin’ treats over safety alert
FDA announces recall affecting millions of Dunkin' baked goods including beloved Munchkins, donuts, and fritters - here's ...
Scotiabank raises Travere stock target to $32 on FDA update
Scotiabank (TSX:BNS) analyst Greg Harrison increased the price target on Travere Therapeutics (NASDAQ:TVTX) to $32.00, up from the previous $27.00, while retaining a Sector Outperform rating for the ...